Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
1.800
-0.010 (-0.55%)
Feb 27, 2026, 4:00 PM EST - Market closed
Serina Therapeutics Market Cap
Serina Therapeutics has a market cap or net worth of $19.41 million as of February 27, 2026. Its market cap has decreased by -56.91% in one year.
Market Cap
19.41M
Enterprise Value
14.18M
1-Year Change
-56.91%
Ranking
Category
Stock Price
$1.80
Market Cap Chart
Since March 27, 2024, Serina Therapeutics's market cap has decreased from $125.13M to $19.41M, a decrease of -84.48%. That is a compound annual growth rate of -62.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 19.41M | -4.83% |
| Dec 31, 2025 | 20.40M | -56.64% |
| Dec 31, 2024 | 47.05M | -62.40% |
| Mar 27, 2024 | 125.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neuphoria Therapeutics | 22.37M |
| FibroBiologics | 22.21M |
| Pasithea Therapeutics | 20.36M |
| VYNE Therapeutics | 19.99M |
| Polyrizon | 19.91M |
| Cadrenal Therapeutics | 19.85M |
| Intensity Therapeutics | 19.41M |
| BioAtla | 18.37M |